Literature DB >> 7730237

Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate.

K J Pörnull1, G Rodrigo, K Dornbusch.   

Abstract

A septicaemia Klebsiella pneumoniae isolate from Greece (Ath1) was shown to be resistant to third generation cephalosporins, aztreonam and cefoxitin and this resistance was not decreased in the presence of clavulanic acid. The gene coding for the resistance phenotype, associated with a beta-lactamase showing cephalosporinase activity and a pI of 8.6, could be transferred into Escherichia coli K-12 by conjugation and transformation. DNA-hybridisation showed that this gene was located on two different plasmids, 7.8 and 80 kb respectively. The larger, conjugative plasmid also carried genes coding for another beta-lactamase (pI 6.6) and resistance to aminoglycosides, tetracycline, chloramphenicol and trimethoprim. Under highly stringent conditions the gene coding for the pI 8.6 beta-lactamase hybridised with chromosomal DNA from Citrobacter freundii OS60 but not from E. coli or Enterobacter cloacae. Furthermore, the restriction map of this beta-lactamase gene corresponded to that of ampC from C. freundii OS60. The regulatory ampR gene could not be detected in the plasmid DNA from the Ath1 K. pneumoniae by DNA hybridisation. The relationship between a plasmid-mediated extended spectrum beta-lactamase in a K. pneumoniae septicaemia isolate and chromosomal AmpC beta-lactamase from C. freundii was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7730237     DOI: 10.1093/jac/34.6.943

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.

Authors:  P E Coudron; E S Moland; K S Thomson
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Authors:  K S Thomson; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

3.  Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).

Authors:  M Gazouli; L S Tzouvelekis; E Prinarakis; V Miriagou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

4.  Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Authors:  M G Cormican; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae.

Authors:  K Nasim; S Elsayed; J D D Pitout; J Conly; D L Church; D B Gregson
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 6.  Controversies about extended-spectrum and AmpC beta-lactamases.

Authors:  K S Thomson
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.